Chinese Journal of Pharmaceuticals
|
2022, 53(5): 629-638
Domestic and Overseas Research Progress of Transdermal Tulobuterol Patches
Full
Caixia YU
1, 2, Lina YANG
2, Jianhao TENG
2, Huafei LUO
2, 3, Fuli ZHANG
2, Liya LIN
2, *
Affiliations
- 1.School of Chemistry and Chemical Engineering, Shanghai University of Engineering and Science, Shanghai 201620
- 2.Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203
- 3.National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
Published: 2022-05-10
doi: 10.16522/j.cnki.cjph.2022.05.005
Outline
Transdermal tulobuterol patch, which contains a β2-adrenergic receptor-specific agonist, is the first long-acting bronchodilator that can be used as a transdermal patch. This paper traces the prescription and technology of the original patches and combs the research progress at home and abroad to provide ideas for the development of domestic generic tulobuterol patches.
asthma
/
chronic obstructive pulmonary disease
/
tulobuterol
/
transdermal patch
/
prescription and technology
/
quality evaluation
于彩霞, 杨丽娜, 滕健皓, 罗华菲, 张福利, 林丽娅.
妥洛特罗透皮贴剂的国内外研究进展.
中国医药工业杂志,
2022
, 53
(5)
: 629
-638
.
DOI: 10.16522/j.cnki.cjph.2022.05.005
Caixia YU, Lina YANG, Jianhao TENG, Huafei LUO, Fuli ZHANG, Liya LIN.
Domestic and Overseas Research Progress of Transdermal Tulobuterol Patches[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(5)
: 629
-638
.
DOI: 10.16522/j.cnki.cjph.2022.05.005
Year 2022 volume 53 Issue 5
91
23
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.05.005
- Receive Date:2021-10-29
- Online Date:2026-11-12
- Published:2022-05-10